Blunted Cardiomyocyte Remodeling Response in Exercise-Resistant Rats  by Wisløff, Ulrik et al.
FIGURE 1 Time Course of Gastroesophageal Injury After Atrial Fibrillation Ablation
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(A) Time course of gastroparesis diagnosis stratiﬁed by patients with spontaneous
resolution of symptoms (n ¼ 59, red) and patients whose symptoms remain unresolved
(n ¼ 4, blue). (B) Time course of esophageal injury diagnosis stratiﬁed by patients with
spontaneous resolution of ulcer symptoms (n ¼ 37, red), patients whose ulcer symptoms
did not resolve spontaneously but did not have esophageal perforation (n ¼ 14, blue),
and patients in whom esophageal perforation developed (n ¼ 31, green).
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1378study, it is impossible to determine causation versus
correlation.
We observed a bimodal temporal distribution of
gastroesophageal injury after AF ablation, and all
gastroparesis and esophageal injury diagnosed in the
ﬁrst 5 days after ablation resolved spontaneously.
Symptom onset of gastric and esophageal injury more
than 5 days after AF ablation is concerning for moresevere injury. Our data reinforce the importance of
close postoperative follow-up after AF ablation, even
if patients do not report symptoms in the ﬁrst few
days after ablation of the posterior LA wall.*Chirag R. Barbhaiya, MD
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Remodeling Response in
Exercise-Resistant RatsIncreasing a subject’s aerobic exercise capacity with
training decreases cardiovascular morbidity and mor-
tality. Of major concern is the key observation that
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1379up to 20% of subjects demonstrate little or no change
in maximal oxygen consumption (VO2max) with exer-
cise training (1) and can be considered exercise
resistant. Our goal with the current research was
to test the hypothesis that variation in training
response is associated with cardiomyocyte functional
response to training.
Exercise capacity can be divided into 2 compo-
nents: an innate capacity operating in the untrained
state, followed by an adaptive capacity acquired in
response to exercise training. Previously, we devel-
oped rat models of low and high innate exercise
capacity via 2-way artiﬁcial selective breeding and
showed that high-intensity aerobic interval training
improved VO2max by increasing cardiomyocyte
function in female rats with low innate exercise
capacity (2). To improve our understanding of
adaptive exercise capacity, we developed a second
contrasting rat model system of high response
trainers (HRT) and low response trainers (LRT); gain
in maximal treadmill running distance with endur-
ance training was used as the selection criterion.
After 7 generations of selection (n ¼ 1,371), HRT
could improve running distance by 46% with
training, whereas the LRT change was equivalent to
a 2% loss in capacity; an estimated 10% of the
variation in training response was caused by geno-
typic variance (3). Critical to this second model
system, LRT and HRT demonstrated similar innate
running capacities and body weights. In the current
study, we compared cardiomyocytes isolated from
the left ventricle of LRT and HRT female rats in theFIGURE 1 LRT Rats Fail to Demonstrate Gains in Exercise Capacity i
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Maximal oxygen consumption (VO2max) measured before and after 8 we
trainers [HRT] (p < 0.001).sedentary condition and in rats trained (TR) for
8 weeks using a high-intensity aerobic interval
training protocol proven superior for increasing
VO2max and cardiac function in rats with low
exercise tolerance (2).
HRT and LRT did not differ in VO2max before
training. After training, HRT rats demonstrated a 40%
increase in VO2max, whereas it remained unchanged
in LRT rats (Figure 1). Cardiomyocytes from the left
ventricle were isolated and prepared for confocal
microscopy for dynamic cell measurements and
stimulated at 7 Hz. In the sedentary condition, left
ventricular (LV) cardiomyocytes from the HRT, rela-
tive to the LRT, were both signiﬁcantly longer and
narrower; these dimensional differences resulted in a
higher length-to-width ratio and a lower calculated
LV cell volume. Training resulted in no adaptive
changes in LV cell width or width-to-length ratio, and
maladaptive decreases in LV cell length and cell vol-
ume, in the LRT rats. In contrast, training uniformly
produced positive adaptive morphometric increases
in LV cardiomyocyte length, width, and volume in the
HRT rats (p value for interaction of sedentary-TR
difference between LRT and HRT <0.05; morpho-
metric data not shown). In line with VO2max,
contractility did not differ between LRT and HRT in
the sedentary condition but differed in the TR con-
dition. HRT-TR demonstrated a 30% increase in
fractional shortening, an 18% increase in speed of
shortening, and a 12% increase in relengthening in LV
cardiomyocytes, whereas no such increases occurred
in LRT-TR. In addition, 4 measures of intracellularn Response to Exercise Training Compared With HRT Rats
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1380calcium ion (Ca2þ) cycling demonstrated a similar
pattern to contractility for: 1) twitch-stimulated Ca2þ
amplitude; 2) sarcoplasmic reticulum Ca2þ load
measured as caffeine-stimulated Ca2þ amplitude;
3) rate of Ca2þ release measured as time to peak Ca2þ
transient; and 4) rate of diastolic Ca2þ removal
measured as time to Ca2þ transient decay (p value
for interaction of sedentary-TR difference between
LRT and HRT: twitch- and caffeine-induced Ca2þ
amplitude <0.001; time to 50% Ca2þ peak <0.05; and
Ca2þ decay <0.01; data not shown).
A microarray experiment of the LV free wall iden-
tiﬁed 360 differentially expressed genes (DEGs) be-
tween HRT-sedentary relative to LRT-sedentary and
324 DEGs between HRT-TR relative to LRT-TR (the
National Center for Biotechnology Information’s
Gene Expression Omnibus accession number
GSE20997; UniGene identiﬁers were available for
w30% of Applied Biosystems 1700 Rat Genome Sur-
vey chip version 1.0 [updated probe annotation]). Of
those, osteoglycin, an extracellular matrix protein,
ranked as the greatest DEG, and was decreased in
HRT relative to LRT in both the sedentary and TR
conditions (–2.3 and –4.6 fold, respectively). We also
performed a high-throughput functional annotation
analysis (using the DAVID database) to identify
enriched biological themes among the DEGs. In the
sedentary condition, a gene set involving 5% of the
DEGs were mapped to 3 serine-related activity terms
that were enriched 5-fold in HRT relative to LRT.
Among these, the gene with the greatest differential
(3-fold higher in HRT relative to LRT) was kallikrein-
related peptidase 12, a serine protease predicted
to be a strong effector of cell growth and response.
In the TR condition, 7% to 12% of the DEGs formed
gene sets that were identiﬁed with terms pertaining
to cell adhesion. Genes up-regulated in HRT in-
cluded the cadherin-associated protein catenin and
members of the integrin and metalloproteinase-
disintegrin families; all are critically important in
regulating angiogenesis, neurogenesis, and tissue
development.
By developing a contrasting rat model system via
artiﬁcial selection, we report the following (at several
levels of organization): 1) cardiomyocyte remodeling
accompanies expansion of VO2max in response to
training; and 2) molecular phenotypes involving
extracellular matrix genes for growth signaling and
cell adhesion are a central feature underlying the
variations in response to training (4,5).Ulrik Wisløff, PhD
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and Exercise Capacity
in Patients With
Colorectal Cancer
Does Anticancer Therapy Matter?We congratulate Cramer et al. (1) for their recent
evaluation of factors associated with decreased ex-
ercise tolerance (i.e., peak VO2) in a cross-sectional
cohort of patients with colorectal cancer (CRC),
heart failure, and healthy control subjects. As out-
lined in the accompanying editorial (2), this is a crit-
ical area of investigation that provides important
information to characterize, monitor, and manage
toxic effects across the cancer survivorship contin-
uum. However, there are several notable limitations
to the study, raising questions surrounding the val-
idity of the central conclusion that “ﬁndings were
evident independently of whether patients were un-
dergoing chemotherapy.”
